Multiple sclerosis is often said to be an incurable, progressive, and degenerative disease. It is our hypothesis that some of you do not, or will not, have a progressive disease. The goal of this MS study is to collect as much data as possible over a five-year period with the hope of fiding dietary and lifestyle factors associated with a slower disease progression. To read more about this study, please click on the study title above.
Participate in a Study
The goal of this PD study is to collect as much data as possible over a five-year period with the hope of finding dietary and lifestyle factors associated with a slower disease progression.
To participate in or read more about this study click on the study title above.
Prospective Matched Controlled Outcomes study is funded by NIH/NCCAM and conducted by Bastyr University Research Institute and Fred Hutchinson Cancer Research Center.
This study will evaluate quercitin’s effects on blood glucose and blood vessel function (endothelial function) in patients with type 2 diabetes in comparison to placebo and Acarbose, a pharmaceutical anti-diabetic agent.
Cannabis has been legalized in multiple states, both medically and recreationaly, and its use becoming more widely accepted. This survey seeks to describe the use patterns, beliefs, and any therapeutic benefits or side effects experienced by Cannabis users.
The purpose of this project is to study the alterations in iron metabolism present in patients with Parkinson’s disease as compared to healthy subjects, and the effect of lifestyle habits on iron levels.
We are recruiting both healthy participants (age 52-82) and PD patients: if interested, please call 425-602-3316.
This case-control study will recruit individuals with a diagnosis of MS and healthy controls. Individuals will be asked to come to Bastyr Clinical Research Center for a single study visit, at which time dietary intake, current medications and supplements, other medical diagnoses, and coagulation will be evaluated.